Could a cannabis extract help ease autism symptoms? major trial launches
NCT ID NCT07257939
Summary
This study aims to see if a daily liquid made from medicinal cannabis (called NTI164) can help reduce the core symptoms of autism spectrum disorder (ASD) compared to a placebo. It will involve 98 children and young adults aged 6 to 25 with moderate to severe autism. Participants will take the study liquid or a placebo for 16 weeks, and researchers will measure changes in social skills, behavior, anxiety, and sleep.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Monash Health
Clayton, Victoria, 3168, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.